23andMe is getting serious about drug development — and it could signal a fresh approach to finding new medicines
23andMe, a company known for its consumer genetics test, is also looking to develop new drugs.
The company raised $250 million on Tuesday, and the funding will in part go toward drug development.
While drug development and consumer genetics tests might seem like vastly different businesses, the link could be critical to finding new treatments for diseases.
23andMe is getting serious about drug development.
On Tuesday, 23andMe announced that it had raised $250 million valuing the company at a reported $1.5 billion, and said that that funding will in part go toward developing 23andMe-made therapeutics. It’ll also help the …read more
You may be interested
Animal cruelty: RSPCA seeking identity of drivers who strapped puppy in cage to roof of car – Courier Maildoyelteam - Sep 25, 2017
Courier MailThese were the conditions a young puppy was subjected to over the weekend when it was spotted in an…
Eunji Ban murder-accused had gone out looking to kill someone: Court – The Sydney Morning Heralddoyelteam - Sep 25, 2017
The Sydney Morning HeraldThe legal team for a man accused of murdering a South Korean student in the Brisbane CBD…
THE CHATBOT MONETIZATION REPORT: Sizing the market, key strategies, and how to navigate the chatbot opportunity (FB, AAPL, GOOG)doyelteam - Sep 25, 2017
This is a preview of a research report from BI Intelligence, Business Insider's premium research service. To learn more about…